Your browser doesn't support javascript.
loading
The distinct genetic pattern of ALS in Turkey and novel mutations.
Özoguz, Aslihan; Uyan, Özgün; Birdal, Günes; Iskender, Ceren; Kartal, Ece; Lahut, Suna; Ömür, Özgür; Agim, Zeynep Sena; Eken, Asli Gündogdu; Sen, Nesli Ece; Kavak, Pinar; Saygi, Ceren; Sapp, Peter C; Keagle, Pamela; Parman, Yesim; Tan, Ersin; Koç, Filiz; Deymeer, Feza; Oflazer, Piraye; Hanagasi, Hasmet; Gürvit, Hakan; Bilgiç, Basar; Durmus, Hacer; Ertas, Mustafa; Kotan, Dilcan; Akalin, Mehmet Ali; Güllüoglu, Halil; Zarifoglu, Mehmet; Aysal, Fikret; Dösoglu, Nilgün; Bilguvar, Kaya; Günel, Murat; Keskin, Özlem; Akgün, Tahsin; Özçelik, Hilmi; Landers, John E; Brown, Robert H; Basak, A Nazli.
Afiliação
  • Özoguz A; Suna and Inan Kiraç Foundation, Neurodegeneration Research Laboratory (NDAL), Molecular Biology and Genetics Department, Bogaziçi University, Istanbul, Turkey.
  • Uyan Ö; Suna and Inan Kiraç Foundation, Neurodegeneration Research Laboratory (NDAL), Molecular Biology and Genetics Department, Bogaziçi University, Istanbul, Turkey.
  • Birdal G; Suna and Inan Kiraç Foundation, Neurodegeneration Research Laboratory (NDAL), Molecular Biology and Genetics Department, Bogaziçi University, Istanbul, Turkey.
  • Iskender C; Suna and Inan Kiraç Foundation, Neurodegeneration Research Laboratory (NDAL), Molecular Biology and Genetics Department, Bogaziçi University, Istanbul, Turkey.
  • Kartal E; Suna and Inan Kiraç Foundation, Neurodegeneration Research Laboratory (NDAL), Molecular Biology and Genetics Department, Bogaziçi University, Istanbul, Turkey.
  • Lahut S; Suna and Inan Kiraç Foundation, Neurodegeneration Research Laboratory (NDAL), Molecular Biology and Genetics Department, Bogaziçi University, Istanbul, Turkey.
  • Ömür Ö; Suna and Inan Kiraç Foundation, Neurodegeneration Research Laboratory (NDAL), Molecular Biology and Genetics Department, Bogaziçi University, Istanbul, Turkey.
  • Agim ZS; Suna and Inan Kiraç Foundation, Neurodegeneration Research Laboratory (NDAL), Molecular Biology and Genetics Department, Bogaziçi University, Istanbul, Turkey.
  • Eken AG; Suna and Inan Kiraç Foundation, Neurodegeneration Research Laboratory (NDAL), Molecular Biology and Genetics Department, Bogaziçi University, Istanbul, Turkey.
  • Sen NE; Suna and Inan Kiraç Foundation, Neurodegeneration Research Laboratory (NDAL), Molecular Biology and Genetics Department, Bogaziçi University, Istanbul, Turkey.
  • Kavak P; Computer Engineering Department, Bogaziçi University, Istanbul, Turkey.
  • Saygi C; Suna and Inan Kiraç Foundation, Neurodegeneration Research Laboratory (NDAL), Molecular Biology and Genetics Department, Bogaziçi University, Istanbul, Turkey.
  • Sapp PC; Neurology Department, Medical School, University of Massachusetts, Worcester, MA, USA.
  • Keagle P; Neurology Department, Medical School, University of Massachusetts, Worcester, MA, USA.
  • Parman Y; Neurology Department, Istanbul Medical School, Istanbul University, Istanbul, Turkey.
  • Tan E; Neurology Department, Medical School, Hacettepe University, Ankara, Turkey.
  • Koç F; Neurology Department, Medical School, Çukurova University, Adana, Turkey.
  • Deymeer F; Neurology Department, Istanbul Medical School, Istanbul University, Istanbul, Turkey.
  • Oflazer P; Neurology Department, Istanbul Medical School, Istanbul University, Istanbul, Turkey.
  • Hanagasi H; Neurology Department, Istanbul Medical School, Istanbul University, Istanbul, Turkey.
  • Gürvit H; Neurology Department, Istanbul Medical School, Istanbul University, Istanbul, Turkey.
  • Bilgiç B; Neurology Department, Istanbul Medical School, Istanbul University, Istanbul, Turkey.
  • Durmus H; Neurology Department, Istanbul Medical School, Istanbul University, Istanbul, Turkey.
  • Ertas M; Department of Neurology, Liv Hospital, Istanbul, Turkey.
  • Kotan D; Faculty of Medicine, Department of Neurology, Sakarya University, Sakarya, Turkey.
  • Akalin MA; Neurology Department, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey.
  • Güllüoglu H; Department of Neurology, Medical Park Izmir Hospital, Izmir, Turkey.
  • Zarifoglu M; Department of Neurology, School of Medicine, Uludag University, Bursa, Turkey.
  • Aysal F; Bakirköy Research and Training Hospital for Neurologic and Psychiatric Diseases, Istanbul, Turkey.
  • Dösoglu N; Department of Microbiology, Haydarpasa Numune Education and Research Hospital, Istanbul, Turkey.
  • Bilguvar K; Department of Neurosurgery, Yale School of Medicine, New Haven, CT, USA.
  • Günel M; Department of Neurosurgery, Yale School of Medicine, New Haven, CT, USA.
  • Keskin Ö; Chemical and Biological Engineering Department, Koç University, Istanbul, Turkey.
  • Akgün T; Department of Anesthesiology and Reanimation, American Hospital, Istanbul, Turkey.
  • Özçelik H; Department of Pathology and Laboratory Medicine, Samuel Lunenfeld Research Institute, University of Toronto, Toronto, Ontario, Canada.
  • Landers JE; Neurology Department, Medical School, University of Massachusetts, Worcester, MA, USA.
  • Brown RH; Neurology Department, Medical School, University of Massachusetts, Worcester, MA, USA.
  • Basak AN; Suna and Inan Kiraç Foundation, Neurodegeneration Research Laboratory (NDAL), Molecular Biology and Genetics Department, Bogaziçi University, Istanbul, Turkey. Electronic address: basak@boun.edu.tr.
Neurobiol Aging ; 36(4): 1764.e9-1764.e18, 2015 Apr.
Article em En | MEDLINE | ID: mdl-25681989
ABSTRACT
The frequency of amyotrophic lateral sclerosis (ALS) mutations has been extensively investigated in several populations; however, a systematic analysis in Turkish cases has not been reported so far. In this study, we screened 477 ALS patients for mutations, including 116 familial ALS patients from 82 families and 361 sporadic ALS (sALS) cases. Patients were genotyped for C9orf72 (18.3%), SOD1 (12.2%), FUS (5%), TARDBP (3.7%), and UBQLN2 (2.4%) gene mutations, which together account for approximately 40% of familial ALS in Turkey. No SOD1 mutations were detected in sALS patients; however, C9orf72 (3.1%) and UBQLN2 (0.6%) explained 3.7% of sALS in the population. Exome sequencing revealed mutations in OPTN, SPG11, DJ1, PLEKHG5, SYNE1, TRPM7, and SQSTM1 genes, many of them novel. The spectrum of mutations reflect both the distinct genetic background and the heterogeneous nature of the Turkish ALS population.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Superóxido Dismutase / Proteínas / Proteína FUS de Ligação a RNA / Estudos de Associação Genética / Esclerose Lateral Amiotrófica / Mutação Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País como assunto: Asia Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Superóxido Dismutase / Proteínas / Proteína FUS de Ligação a RNA / Estudos de Associação Genética / Esclerose Lateral Amiotrófica / Mutação Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País como assunto: Asia Idioma: En Ano de publicação: 2015 Tipo de documento: Article